Lipopeptide antifungal agents: Amine conjugates of the semi-synthetic pneumocandins L-731,373 and L-733,560

被引:5
作者
Zambias, RA
James, C
Abruzzo, GK
Bartizal, KF
Hajdu, R
Thompson, R
Nollstadt, KH
Marrinan, J
Balkovec, JM
机构
[1] MERCK RES LABS,DEPT MED CHEM,RAHWAY,NJ 07065
[2] MERCK RES LABS,DEPT INFECT DIS RES,RAHWAY,NJ 07065
[3] MERCK RES LABS,DEPT PARASITE BIOCHEM & CELL BIOL,RAHWAY,NJ 07065
[4] MERCK RES LABS,DEPT ANTIBIOT DISCOVERY & DEV,RAHWAY,NJ 07065
关键词
D O I
10.1016/S0960-894X(97)00359-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Amine conjugates of the semi-synthetic 1,3-beta-(D)-glucan synthesis inhibitors L-731,373 (3) and L-733,560 (4) were prepared and evaluated for in vitro and in vivo antifungal activity. Tricationic analogs were more potent than the dicationic which were more potent than the monocationic. The L-ornithine conjugate of 4 possessed excellent pharmacokinetic parameters but lacked sufficient antifungal spectrum for development. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:2021 / 2026
页数:6
相关论文
共 13 条
[1]   EVALUATION OF WATER-SOLUBLE PNEUMOCANDIN ANALOGS L-733560, L-705589, AND L-731373 WITH MOUSE MODELS OF DISSEMINATED ASPERGILLOSIS, CANDIDIASIS, AND CRYPTOCOCCOSIS [J].
ABRUZZO, GK ;
FLATTERY, AM ;
GILL, CJ ;
KONG, L ;
SMITH, JG ;
KRUPA, D ;
PIKOUNIS, VB ;
KROPP, H ;
BARTIZAL, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) :1077-1081
[2]  
Balkovec J.M., 1994, EXPERT OPIN INV DRUG, V3, P65, DOI [10.1517/13543784.3.2.65, DOI 10.1517/13543784.3.2.65]
[3]  
BALKOVEC JM, 1995, NAT ACS M CHIC
[4]   IN-VITRO EVALUATION OF THE PNEUMOCANDIN ANTIFUNGAL AGENT L-733560, A NEW WATER-SOLUBLE HYBRID OF L-705589 AND L-731373 [J].
BARTIZAL, K ;
SCOTT, T ;
ABRUZZO, GK ;
GILL, CJ ;
PACHOLOK, C ;
LYNCH, L ;
KROPP, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) :1070-1076
[5]   INVITRO ANTIFUNGAL ACTIVITIES AND INVIVO EFFICACIES OF 1,3-BETA-D-GLUCAN SYNTHESIS INHIBITORS L-671,329, L-646,991, TETRAHYDROECHINOCANDIN-B, AND L-687,781, A PAPULACANDIN [J].
BARTIZAL, K ;
ABRUZZO, G ;
TRAINOR, C ;
KRUPA, D ;
NOLLSTADT, K ;
SCHMATZ, D ;
SCHWARTZ, R ;
HAMMOND, M ;
BALKOVEC, J ;
VANMIDDLESWORTH, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1648-1657
[6]   SYNTHESIS AND ANTIFUNGAL ACTIVITY OF NOVEL CATIONIC PNEUMOCANDIN B-O DERIVATIVES [J].
BOUFFARD, FA ;
ZAMBIAS, RA ;
DROPINSKI, JF ;
BALKOVEC, JM ;
HAMMOND, ML ;
ABRUZZO, GK ;
BARTIZAL, KF ;
MARRINAN, JA ;
KURTZ, MB ;
MCFADDEN, DC ;
NOLLSTADT, KH ;
POWLES, MA ;
SCHMATZ, DM .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (02) :222-225
[7]   The future of antifungal therapy [J].
Graybill, JR .
CLINICAL INFECTIOUS DISEASES, 1996, 22 :S166-S178
[8]   Lipid formulations of amphotericin B: Recent progress and future directions [J].
Hiemenz, JW ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 1996, 22 :S133-S144
[9]  
SCHMATZ D, 1995, ANTIMICROB AGENTS CH, V37, P1320
[10]   PNEUMOCANDINS FROM ZALERION-ARBORICOLA .4. BIOLOGICAL EVALUATION OF NATURAL AND SEMISYNTHETIC PNEUMOCANDINS FOR ACTIVITY AGAINST PNEUMOCYSTIS-CARINII AND CANDIDA SPECIES [J].
SCHMATZ, DM ;
ABRUZZO, G ;
POWLES, MA ;
MCFADDEN, DC ;
BALKOVEC, JM ;
BLACK, RM ;
NOLLSTADT, K ;
BARTIZAL, K .
JOURNAL OF ANTIBIOTICS, 1992, 45 (12) :1886-1891